Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid Tumors.

Anticancer research - 1 Dec 2024

Lee Yehyeong, Kim Yonghyo, Shin Hyeran, Ryu Yeong Chan, Kang Dong-Woo, Kim Tae Il, Cho Yong-Hee

Abstract excerpt

BACKGROUND/AIM: Desmoid tumors (DTs), also referred to as aggressive fibromatosis, originate from connective tissues and typically manifest with a propensity for local invasion. Despite extensive research efforts aimed at exploring novel anti-tumor agents for DTs, the development of effective clinical management strategies remains an ongoing challenge due to the limited success of current treatments, which...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Adenomatous Polyposis Coli Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to Colorectal Neoplasms

Share to Desmoid Tumors

Share to Topoisomerase II Inhibitors

Share to Tumor Suppressor Protein p53

Share to Xenograft Model Antitumor Assays

Source

Identifiers

PMID: 39626909
DOI: 10.21873/anticanres.17359

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid Tumors.PMID 39626909Read ↗

Chlorhexidine Dihydrochloride Shows Anti-tumor Effects in Desmoid Tumors and Colorectal Cancer.Semantic proximity Read ↗

Evaluation of diagnostic algorithm and therapeutic interventions for intra-abdominal desmoid tumors.Semantic proximity Read ↗

Efficacy of auranofin as an inhibitor of desmoid progression.Semantic proximity Read ↗

Establishment and characterization of NCC-DSM1-C1: a novel cell line derived from a patient with desmoid fibromatosis.Semantic proximity Read ↗

Desmoid tumor: a disease opportune for molecular insights.Semantic proximity Read ↗

Trends in diagnostic and therapeutic strategies for extra-abdominal desmoid-type fibromatosis: Japanese musculoskeletal oncology group questionnaire survey.Semantic proximity Read ↗

Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor.Semantic proximity Read ↗

Activated Signaling Pathways and Targeted Therapies in Desmoid-Type Fibromatosis: A Literature ReviewSemantic proximity Read ↗

Optimal therapy for desmoid tumors: current options and challenges for the future.Semantic proximity Read ↗

Immunohistochemical evaluation of potential molecular targets of desmoid-type fibromatosis.Semantic proximity Read ↗

Multiomics profiling reveals excessive fibroblast activation and collagen deposition are associated with poor prognosis in desmoid tumorsSemantic proximity Read ↗

A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.